The PI3K–AKT network at the interface of oncogenic signalling and cancer metabolism

G Hoxhaj, BD Manning - Nature Reviews Cancer, 2020 - nature.com
The altered metabolic programme of cancer cells facilitates their cell-autonomous
proliferation and survival. In normal cells, signal transduction pathways control core cellular …

Lipid metabolism reprogramming and its potential targets in cancer

C Cheng, F Geng, X Cheng, D Guo - Cancer communications, 2018 - Springer
Reprogramming of lipid metabolism is a newly recognized hallmark of malignancy.
Increased lipid uptake, storage and lipogenesis occur in a variety of cancers and contribute …

Wogonin and its analogs for the prevention and treatment of cancer: A systematic review

K Banik, E Khatoon, C Harsha, V Rana… - Phytotherapy …, 2022 - Wiley Online Library
The medicinal plant Scutellaria baicalensis, commonly known as Chinese skullcap or
Huang‐Qin, has been used as a traditional medicine for several thousand years. The roots …

Lipid metabolism in cancer progression and therapeutic strategies

Y Fu, T Zou, X Shen, PJ Nelson, J Li, C Wu, J Yang… - MedComm, 2021 - Wiley Online Library
Dysregulated lipid metabolism represents an important metabolic alteration in cancer. Fatty
acids, cholesterol, and phospholipid are the three most prevalent lipids that act as energy …

How the Warburg effect supports aggressiveness and drug resistance of cancer cells?

P Icard, S Shulman, D Farhat, JM Steyaert… - Drug Resistance …, 2018 - Elsevier
Cancer cells employ both conventional oxidative metabolism and glycolytic anaerobic
metabolism. However, their proliferation is marked by a shift towards increasing glycolytic …

ACSL4 reprograms fatty acid metabolism in hepatocellular carcinoma via c-Myc/SREBP1 pathway

J Chen, C Ding, Y Chen, W Hu, C Yu, C Peng, X Feng… - Cancer letters, 2021 - Elsevier
Lipid metabolic reprogramming plays a pivotal role in hepatocellular carcinoma (HCC)
development, but the underlying mechanisms are incompletely characterized. Long chain …

Targeting AKT/mTOR in oral cancer: mechanisms and advances in clinical trials

C Harsha, K Banik, HL Ang, S Girisa… - International journal of …, 2020 - mdpi.com
Oral cancer (OC) is a devastating disease that takes the lives of lots of people globally every
year. The current spectrum of treatment modalities does not meet the needs of the patients …

ATP citrate lyase: A central metabolic enzyme in cancer

P Icard, Z Wu, L Fournel, A Coquerel, H Lincet… - Cancer letters, 2020 - Elsevier
ACLY links energy metabolism provided by catabolic pathways to biosynthesis. ACLY,
which has been found to be overexpressed in many cancers, converts citrate into acetyl-CoA …

[HTML][HTML] Influence of cholesterol on cancer progression and therapy

SS Mayengbam, A Singh, AD Pillai, MK Bhat - Translational oncology, 2021 - Elsevier
Cholesterol is a fundamental molecule necessary for the maintenance of cell structure and is
vital to various normal biological functions. It is a key factor in lifestyle-related diseases …

ATP citrate lyase (ACLY) inhibitors: An anti-cancer strategy at the crossroads of glucose and lipid metabolism

C Granchi - European journal of medicinal chemistry, 2018 - Elsevier
ATP citrate lyase (ACLY) is a cytosolic homotetrameric enzyme that catalyzes the conversion
of citrate and coenzyme A (CoA) to acetyl-CoA and oxaloacetate, with the simultaneous …